<b>Conclusions:</b> These findings suggest that FOXM1, MCM3, SH3BP5, and PAPSS2 could serve as biomarkers for early prognosis, diagnosis, and targeted therapy in patients with cervical and ovarian cancer. The gene discussed is SH3BP5; the disease is ovarian cancer.